Cerba HealthCare is a leading French-based healthcare company that specializes in clinical laboratory testing and diagnostic services. The company was founded in 1967 and is headquartered in Saint-Ouen-l'Aumône, France. Cerba HealthCare offers a wide range of medical diagnostic services, including clinical pathology, genetics, anatomical pathology, and clinical trial testing.

The company operates a network of over 8,000 healthcare professionals and experts worldwide and provides its services to healthcare providers, hospitals, and pharmaceutical companies. Cerba HealthCare aims to deliver high-quality and innovative diagnostic solutions to support patient care and improve health outcomes. On a global scale, Cerba HealthCare has a significant presence with operations in more than 40 countries.

The company has established a strong network of subsidiaries, joint ventures, and partnerships to expand its reach and expertise. One of its notable subsidiaries is Biomnis, a major clinical pathology laboratory in France. Cerba HealthCare also has joint ventures with various partners, such as Nalagenetics in Israel and SYNLAB International in Germany.

In terms of market position, Cerba HealthCare is considered one of the largest clinical laboratory groups in Europe. The company has achieved substantial success in global sales, with revenues exceeding €700 million in 2020. Cerba HealthCare's commitment to excellence and ongoing investments in research and development have contributed to its competitive edge in the industry.

The company has consistently focused on innovation and technology-driven advancements to meet the evolving needs of healthcare providers and patients. In recent years, Cerba HealthCare has made significant acquisitions and strategic partnerships to strengthen its position in the international market. One noteworthy event was the acquisition of Equipe Polyvalente de Recherche et de Diagnostic in France, which expanded the company's anatomical pathology services.

Additionally, Cerba HealthCare has undergone a rebranding process, repositioning itself as a global leader in specialty diagnostics. As of the latest available information, Cerba HealthCare continues to drive growth and innovation in the healthcare industry. The company remains dedicated to expanding its global presence and enhancing its products and services to deliver personalized and accurate diagnostic solutions.

Overall, Cerba HealthCare is a leading provider of clinical laboratory testing and diagnostic services globally, with a strong market position and a commitment to innovation and patient care